MUZAFFAR PIRACHA
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism OCEAN SPRINGS, MS NPI 1912950320
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism MS Abbott Laboratories All categories
General Payments — all program years on this page
$8,338.43
- Category: General Payments
- Program years: PY2018–2024
- Record count: 475
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,495.83 across 79 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,495.83 | 79 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $345.55 | 25 |
| Amgen Inc. | $213.03 | 7 |
| Novo Nordisk AS | $147.48 | 9 |
| Radius Health, Inc. | $102.26 | 4 |
| ABBVIE INC. | $86.66 | 5 |
| Merck Sharp & Dohme Corporation | $70.25 | 3 |
| Corcept Therapeutics | $60.66 | 3 |
| PFIZER INC. | $53.92 | 3 |
| Xeris Pharmaceuticals, Inc. | $53.28 | 3 |
| SANOFI-AVENTIS U.S. LLC | $51.94 | 2 |
| Lilly USA, LLC | $37.28 | 2 |
| Actelion Pharmaceuticals US, Inc. | $36.71 | 1 |
| DEXCOM, INC. | $32.62 | 1 |
| Alexion Pharmaceuticals, Inc. | $30.09 | 1 |
| United Therapeutics Corporation | $25.28 | 1 |
| Insulet Corporation | $23.38 | 1 |
| Electromed, Inc. | $22.73 | 3 |
| Regeneron Healthcare Solutions, Inc. | $22.14 | 1 |
| La Jolla Pharmaceutical Company | $21.26 | 1 |
| Ascendis Pharma Inc | $20.45 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.29 | 1 |
| Mallinckrodt Hospital Products Inc. | $18.57 | 1 |
By program year
Records — PY2024 (79)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.